Testing effectiveness (Phase 2)Study completedNCT00156247What this trial is testingAcitretin and Etanercept in PsoriasisWho this might be right forPsoriasis University of Medicine and Dentistry of New Jersey 10
Large-scale testing (Phase 3)Study completedNCT01241591What this trial is testingA Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 1,101
Large-scale testing (Phase 3)Study completedNCT01726933What this trial is testingLAS41008 in Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Almirall, S.A. 839
Large-scale testing (Phase 3)Study completedNCT02362789What this trial is testingSecukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional BiomarkersWho this might be right forPsoriasis Novartis Pharmaceuticals 132
Large-scale testing (Phase 3)Study completedNCT01807520What this trial is testingStudy of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail PsoriasisWho this might be right forModerate to Severe Nail Psoriasis Novartis Pharmaceuticals 198
Large-scale testing (Phase 3)UnknownNCT06110676What this trial is testingEvaluate the Efficacy and Safety of LZM012Who this might be right forPsoriasis Livzon Pharmaceutical Group Inc. 918
Large-scale testing (Phase 3)Study completedNCT03875482What this trial is testingAssess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie 157
Early research (Phase 1)Ended earlyNCT02502188What this trial is testingPhase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type PsoriasisWho this might be right forParapsoriasisHealthy Volunteers Celgene 24
Not applicableStudy completedNCT01077232What this trial is testingDocumentation of Humira in Psoriasis Patients in Routine Clinical PracticeWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 5,442
Large-scale testing (Phase 3)Study completedNCT00710580What this trial is testingStudy Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 350
Large-scale testing (Phase 3)Study completedNCT04761627What this trial is testingInvestigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 494
Testing effectiveness (Phase 2)Study completedNCT03850483What this trial is testingDose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In PsoriasisWho this might be right forPsoriasis Pfizer 344
Post-approval studies (Phase 4)Study completedNCT00940862What this trial is testingEffect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasisVascular InflammationCoronary Atherosclerosis Innovaderm Research Inc. 30
Large-scale testing (Phase 3)Study completedNCT00338754What this trial is testingAdalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Abbott 160
Not applicableStudy completedNCT01316224What this trial is testingPrevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab TreatmentWho this might be right forPsoriasisPsoriatic Arthritis AbbVie (prior sponsor, Abbott) 52
Testing effectiveness (Phase 2)Study completedNCT00606450What this trial is testingDouble-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type PsoriasisWho this might be right forPsoriasis Amgen 260
Testing effectiveness (Phase 2)Study completedNCT06278350What this trial is testingEvaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis InventisBio Co., Ltd 161
Testing effectiveness (Phase 2)Study completedNCT03782792What this trial is testingEffisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular PsoriasisWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 53
Testing effectiveness (Phase 2)Study completedNCT03706209What this trial is testingStudy to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque PsoriasisWho this might be right forPsoriasis MetrioPharm AG 155
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367What this trial is testingTofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Second Affiliated Hospital, Zhejiang University, School of Medicine 135